Learning Manufacturing Pharmaceutical 
Tanveer Naseer
MAY 16, 2011
Russell is an educational psychologist, author, executive coach and management consultant whose clients include Fortune 500 executives in aerospace, healthcare, pharmaceutical and biotechnology, information technology, telecommunications and oil and gas. You can learn more about Russell and his book on his website at RussellBishop.com.
Mad in America
NOVEMBER 13, 2023
Schatzberg has served as a consultant to or received honoraria from Abbott, Bristol-Myers Squibb, Corcept Therapeutics, Forest Laboratories, Janssen, Eli Lilly, Merck, Mitsubishi Pharmaceuticals, Organon, ParkeDavis, Pfizer, Pharmacia–Upjohn, Sanofi, Scirex, SmithKline Beecham, Solvay, and Wyeth–Ayerst.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
OCTOBER 18, 2023
For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. The marketing of medical conditions has become a key plank of pharmaceutical industry marketing. Helping widen the definitions of disease is a key part of marketing those pharmaceutical products.
Mad in America
SEPTEMBER 7, 2024
I spent a long time in OCD therapy and learned a lot about the field. Doctors became hypnotized by the appearance of “science”, even if the literature they consulted was essentially pharmaceutical advertising. Such optimism would be disappointed by dwindling pharmaceutical progress in the later half of the century.
Mad in America
SEPTEMBER 14, 2024
Psychiatric survivor and Shield volunteer Andrea Barnes told Mad in America that she was horrified to learn that Catholic Charities was heavily implicated in Russell’s case. “To Somatics LLC marked a watershed moment for advocates who have fought for decades for ECT device manufacturer accountability.
Insperity
JANUARY 13, 2014
Medical device sales tax – this tax on the sale of certain taxable medical devices will indirectly increase health insurance costs as manufacturers raise prices to cover the tax. Pharmaceutical manufacturer excise tax – annual fee on entities engaged in the business of manufacturing or importing branded prescription drugs.
Inside Workplace Wellness
AUGUST 1, 2018
The timing was good, ASHA's PBM contract is out to bid and I've spent the last four months learning what I need to know to evaluate our options. I was happy to share what I've learned and will summarize what I shared here as well with links to some of the things I mentioned. 3 Evaluate your contract terms.
Expert insights. Personalized for you.
93 
Let's personalize your content